Comprehensive drug profiles

Expert-backed testing to monitor therapy, assess risk, and identify misuse

Mayo Clinic Laboratories’ controlled substance monitoring profiles were developed by the Clinical and Forensic Toxicology Laboratory at Mayo Clinic and are consistent with laboratory medicine practice guidelines established by the American Association for Clinical Chemistry (AACC),2 which were endorsed by the American Academy of Pain Medicine (AAPM). The results of these assays can be used to guide pharmacotherapy decisions while ensuring prescribing adherence to federal and state guidelines through compliance monitoring.

Comprehensive drug profiles TEST MENU

Comprehensive drug profiles

Commonly prescribed benzodiazepines (e.g., alprazolam, clonazepam), opioids (e.g., hydrocodone, oxycodone, methadone), and stimulants (e.g., methylphenidate, amphetamine) present challenges for clinicians due to their high risk of misuse, abuse, and diversion.1

Key testing

  1. Preuss CV, Kalava A, King KC. Prescription of controlled substances: benefits and risks. Treasure Island, FL: StatPearls Publishing; 2019.
  2. Jannetto PJ, Bratanow NC, Clark WA, et al. Executive Summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline — Using Clinic Laboratory Tests to Monitor Drug Therapy in Pain Management Patients. J Applied Lab Med. 2018;2(4):489-526.

Fill out the form below and one of our specialists will be in touch.